澳洲幸运5官方开奖结果体彩网

Docusign Stock Soars as Profit Doubles Expectations on Strong Billings

Docusign website on a laptop

Gabby Jones / Bloomberg via Getty Images

Key Takeaways

  • Docusign's earnings and revenue exceeded forecasts as billings and subscription revenue jumped.
  • The e-document software provider also posted strong new customer growth.
  • Docusign raised its guidance for revenue, billings, and subscription revenue.

Docusign (DOCU) shares soared nearly 20% Friday, a day after the 澳洲幸运5官方开奖结果体彩网:e-document software provider posted better-than-exꦡpected results and raised its▨ guidance as billings and subscription revenue surged.

The company reported third-quarter fiscal 2025 profit of $62.4 million, or $0.30 per share, while analysts surveyed by Visible Alpha projected $30.2 million, or $0.14 per share. Revenue of $754.8 million also beat estimates.

Billings incre♋ased 9% year-over-year to $752.3 million, and subscriꦆption revenue added 8% to $734.7 million.

CEO Says 'Fundamentals Across the Core Business Improved'

澳洲幸运5官方开奖结果体彩网:Chief Executive Officer (CEO) Allan Thygesen said, "Fundamentals across the core business improved, continuing the recent trends." Thygesen added that in addition, Docusign had "sustained momentum in new customer growth at 11% year-over-year to 1.6 million customers."

The company now sees full-year revenue of $2.959 billion to $2.963 billion, compared to the earlier estimate of $2.940 billion to $2.952 billion. It anticipates billings be $3.056 billion to $3.066 billion, versus the previous prediction of $2.990 billion to $3.030 billion. It also boosted its subscription revenue outlook to $2.885 billion to $2.889 billion from $2.864 billion to $2.876 billion.

Shares of Docusign recently traded up 19% at $99.92, their highest level since April 2022.

DOCU

TradingView

Do you have a news tip for Investopedia reporters? Please email us at
Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.
  1. Docusign. “.”

  2. Docusign. "."

  3. Docusign. "."

Compare Accounts
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.

Related Articles